Cargando…

Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma

BACKGROUNDS: Previous studies identified the extent of lymph node dissection for esophagogastric junction (EGJ) carcinoma based on the metastatic incidence. The study aimed to determine the optimal extent and priority of lymphadenectomy based on the therapeutic efficacy from each station. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Rong, Bi, Xiaogang, Fan, Daguang, Du, Qiao, Wang, Rong, Zhao, Baoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743047/
https://www.ncbi.nlm.nih.gov/pubmed/36518305
http://dx.doi.org/10.3389/fonc.2022.913960
_version_ 1784848647612006400
author Liang, Rong
Bi, Xiaogang
Fan, Daguang
Du, Qiao
Wang, Rong
Zhao, Baoyu
author_facet Liang, Rong
Bi, Xiaogang
Fan, Daguang
Du, Qiao
Wang, Rong
Zhao, Baoyu
author_sort Liang, Rong
collection PubMed
description BACKGROUNDS: Previous studies identified the extent of lymph node dissection for esophagogastric junction (EGJ) carcinoma based on the metastatic incidence. The study aimed to determine the optimal extent and priority of lymphadenectomy based on the therapeutic efficacy from each station. METHODS: The studies on the lymph node metastasis (LNM) and therapeutic efficacy index (EI) for EGJ carcinomas were identified until April 2022. The obligatory stations with the LNM rates over 5% and therapeutic EI exceeding 2% should be routinely resected for D2 dissection, whereas the optional stations with EI between 0.5% and 2% should be resected for D3 dissection in selective cases. RESULTS: The survey yielded 16 eligible articles including 6,350 patients with EGJ carcinoma. The metastatic rates exceeded 5% at no. 1, 2, 3, 7, 9, 11p, and 110 stations and were less than 5% in abdominal no. 4sa~6, 8a, 10, 11d, 12a, and 16a2/b1 and mediastinal no. 105~112 stations. Consequently, obligatory stations with EI over 2% were largely determined by the epicenter location and located at the upper perigastric, lower mediastinal, and suprapancreatic zones, corresponding to those with rates of LNM over 5%. Consistent with the LNM rates less than 5%, the optional stations with EI between 0.5% and 2% were largely dependent on the degree of tumor extension toward the lower perigastric, splenic hilar (grecurvature), para-aortic (less curvature of the cardia), and middle or upper mediastinal zones. CONCLUSIONS: The obligatory stations can be resected as an “envelope-like” wrap by transhiatal proximal gastrectomy with lower esophagectomy, whereas the optional stations for dissection are indicated by the tumor extension. The extended gastrectomy is required for the lower perigastric in the stomach-predominant tumor with gastric involvement exceeding 5.0 cm, para-aortic dissection in the less curvature-predominant tumor and splenic hilar dissection in the grecurvature-predominant tumor whereas transthoracic subtotal esophagectomy is required for complete mediastinal dissection and adequate negative margin in the esophagus-predominant tumor with esophageal invasion exceeding 3.0 cm.
format Online
Article
Text
id pubmed-9743047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97430472022-12-13 Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma Liang, Rong Bi, Xiaogang Fan, Daguang Du, Qiao Wang, Rong Zhao, Baoyu Front Oncol Oncology BACKGROUNDS: Previous studies identified the extent of lymph node dissection for esophagogastric junction (EGJ) carcinoma based on the metastatic incidence. The study aimed to determine the optimal extent and priority of lymphadenectomy based on the therapeutic efficacy from each station. METHODS: The studies on the lymph node metastasis (LNM) and therapeutic efficacy index (EI) for EGJ carcinomas were identified until April 2022. The obligatory stations with the LNM rates over 5% and therapeutic EI exceeding 2% should be routinely resected for D2 dissection, whereas the optional stations with EI between 0.5% and 2% should be resected for D3 dissection in selective cases. RESULTS: The survey yielded 16 eligible articles including 6,350 patients with EGJ carcinoma. The metastatic rates exceeded 5% at no. 1, 2, 3, 7, 9, 11p, and 110 stations and were less than 5% in abdominal no. 4sa~6, 8a, 10, 11d, 12a, and 16a2/b1 and mediastinal no. 105~112 stations. Consequently, obligatory stations with EI over 2% were largely determined by the epicenter location and located at the upper perigastric, lower mediastinal, and suprapancreatic zones, corresponding to those with rates of LNM over 5%. Consistent with the LNM rates less than 5%, the optional stations with EI between 0.5% and 2% were largely dependent on the degree of tumor extension toward the lower perigastric, splenic hilar (grecurvature), para-aortic (less curvature of the cardia), and middle or upper mediastinal zones. CONCLUSIONS: The obligatory stations can be resected as an “envelope-like” wrap by transhiatal proximal gastrectomy with lower esophagectomy, whereas the optional stations for dissection are indicated by the tumor extension. The extended gastrectomy is required for the lower perigastric in the stomach-predominant tumor with gastric involvement exceeding 5.0 cm, para-aortic dissection in the less curvature-predominant tumor and splenic hilar dissection in the grecurvature-predominant tumor whereas transthoracic subtotal esophagectomy is required for complete mediastinal dissection and adequate negative margin in the esophagus-predominant tumor with esophageal invasion exceeding 3.0 cm. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9743047/ /pubmed/36518305 http://dx.doi.org/10.3389/fonc.2022.913960 Text en Copyright © 2022 Liang, Bi, Fan, Du, Wang and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liang, Rong
Bi, Xiaogang
Fan, Daguang
Du, Qiao
Wang, Rong
Zhao, Baoyu
Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title_full Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title_fullStr Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title_full_unstemmed Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title_short Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
title_sort mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743047/
https://www.ncbi.nlm.nih.gov/pubmed/36518305
http://dx.doi.org/10.3389/fonc.2022.913960
work_keys_str_mv AT liangrong mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma
AT bixiaogang mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma
AT fandaguang mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma
AT duqiao mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma
AT wangrong mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma
AT zhaobaoyu mappingoflymphnodedissectiondeterminedbytheepicenterlocationandtumorextensionforesophagogastricjunctioncarcinoma